Myxedema

From Wikipedia, the free encyclopedia

ICD9 = | DiseasesDB = 6558 | ICDO = | OMIM = | MedlinePlus = 000353 | eMedicineSubj = med | eMedicineTopic = 1581 | eMedicine_mult = | MeshID = D009230 |Myxedema (English: myxoedema) is a skin and tissue disorder usually due to severe prolonged hypothyroidism. Hypothyroidism can be caused by Hashimoto's thyroiditis, surgical removal of the thyroid, and rarer conditions. Partial forms of myxedema, especially of the lower legs (called pretibial myxedema), occasionally occur in adults with Graves' disease, a cause of hyperthyroidism; or also Hashimoto's thyroiditis without severe hypothyroidism.

Symptoms

Myxedema usually presents itself with some of the following symptoms:
  • Skin thickening
  • Coarse skin
  • Change in facial appearance
  • Thickening nose
  • Swollen lips
  • Puffiness around the eyes
  • Jelly-like infiltrations in subcutaneous tissues
  • Slow speech
  • Mental dullness
  • Lethargy
  • Mental problems
  • Dry skin
  • Yellow skin
  • Swollen subcutaneous tissue
  • Weight gain
  • Constipation
  • Thinning hair
  • Brittle hair
  • Bald patches
  • Muscle pains
  • Deafness
  • Hearing impairment
  • Carpal tunnel syndrome

    • Causes

    Myxedema stemming from both the hyperthyroid and hypothyroid conditions, results from the accumulation of increased amounts of hyaluronic acid and chondroitin sulfate in the dermis in both lesional and normal skin. The mechanism that causes myxedema is still not yet understood, although animal model studies suggest that thyroid hormones affect the synthesis and catabolism of mucopolysaccharides and collagen by dermal fibroblasts. The fibroblasts in the orbital and pretibial dermis share antigenic sites that underlie the autoimmune process that causes Grave's disease. This cross-reaction may contribute to the development of myxedema long after normal levels of thyroid hormones have been restored by treatment.

    Treatment

    Treatment for myxedema is difficult. Systemic or intralesional glucocorticoids, topical glucocorticoids under occlusion or high-dose intravenous immunoglobulin have been reported to offer some relief to patients. Treatment should follow correction of the original hyperthyroidism/hypothyroidism.

    Next Page


    This article is based on an article from Wikipedia, the free encyclopedia and is available under the terms of GNU Free Documentation License.
    In the Wikipedia there is a list with all authors of this article available.